KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Accured Expenses (2017 - 2025)

Guardant Health's Change in Accured Expenses history spans 9 years, with the latest figure at $53.7 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 216.28% year-over-year to $53.7 million; the TTM value through Dec 2025 reached $52.7 million, up 1970.53%, while the annual FY2025 figure was $52.7 million, 1970.53% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $53.7 million at Guardant Health, up from $3.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $53.7 million in Q4 2025 and bottomed at -$28.3 million in Q2 2024.
  • The 5-year median for Change in Accured Expenses is $6.1 million (2021), against an average of $7.5 million.
  • The largest annual shift saw Change in Accured Expenses skyrocketed 1100.5% in 2021 before it crashed 1176.35% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $24.2 million in 2021, then plummeted by 43.83% to $13.6 million in 2022, then tumbled by 257.08% to -$21.4 million in 2023, then surged by 179.46% to $17.0 million in 2024, then skyrocketed by 216.28% to $53.7 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Change in Accured Expenses are $53.7 million (Q4 2025), $3.3 million (Q3 2025), and -$2.7 million (Q2 2025).